# Radiofrequency Ablation in Treating Patients With Refractory or Advanced Lung Cancer

> **NCT00024076** · PHASE2 · COMPLETED · sponsor: **Jonsson Comprehensive Cancer Center** · enrollment: 30 (actual)

## Conditions studied

- Lung Cancer
- Malignant Mesothelioma
- Metastatic Cancer
- Thymoma and Thymic Carcinoma

## Interventions

- **PROCEDURE:** radiofrequency ablation

## Key facts

- **NCT ID:** NCT00024076
- **Lead sponsor:** Jonsson Comprehensive Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-05
- **Primary completion:** 2006-12
- **Final completion:** —
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2020-08-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00024076

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00024076, "Radiofrequency Ablation in Treating Patients With Refractory or Advanced Lung Cancer". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00024076. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*